One Surgeon's Experience with a Low-Opioid Postoperative Pain Protocol for Foot and Ankle Surgery.

IF 0.5 4区 医学 Q4 ORTHOPEDICS
Thomas M Ehlers, Kevin Blue, Dustin L Kruse, Brett D Sachs
{"title":"One Surgeon's Experience with a Low-Opioid Postoperative Pain Protocol for Foot and Ankle Surgery.","authors":"Thomas M Ehlers, Kevin Blue, Dustin L Kruse, Brett D Sachs","doi":"10.7547/22-190","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The opioid epidemic has become incredibly problematic in the United States, leading to more than 80,000 deaths in 2021 alone. There are no studies in the foot and ankle surgery literature attempting to develop a multimodal low-opioid postoperative pain protocol. We present a retrospective evaluation of 20 patients who were prescribed a novel postoperative low-opioid protocol.</p><p><strong>Methods: </strong>Patients who underwent foot and ankle surgery were briefly counseled on expectations and were told to follow a protocol consisting of 400 mg of ibuprofen and 1,000 mg of acetaminophen every 6 hours (either together or alternating) with 15 mg of morphine sulfate immediate release for breakthrough pain.</p><p><strong>Results: </strong>Postoperative subjective pain scores using a visual analog scale from 0 to 10 and the number and type of oral dosing unit (tablets consumed) were taken from the medical record data. The average number of morphine milliequivalents taken among all of the patients during the postoperative period was 27.75. The mean total number of morphine sulfate immediate-release 15-mg tablets taken was 1.85. Average visual analog scale scores on days 3, 5, and 7 were 5.40, 4.50, and 2.25, respectively.</p><p><strong>Conclusions: </strong>This study demonstrates that there may be rampant overprescription of opioids after foot and ankle surgery and that there is a protocol with significantly less opioid burden that is not inferior to current regimens.</p>","PeriodicalId":17241,"journal":{"name":"Journal of the American Podiatric Medical Association","volume":"115 3","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Podiatric Medical Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7547/22-190","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The opioid epidemic has become incredibly problematic in the United States, leading to more than 80,000 deaths in 2021 alone. There are no studies in the foot and ankle surgery literature attempting to develop a multimodal low-opioid postoperative pain protocol. We present a retrospective evaluation of 20 patients who were prescribed a novel postoperative low-opioid protocol.

Methods: Patients who underwent foot and ankle surgery were briefly counseled on expectations and were told to follow a protocol consisting of 400 mg of ibuprofen and 1,000 mg of acetaminophen every 6 hours (either together or alternating) with 15 mg of morphine sulfate immediate release for breakthrough pain.

Results: Postoperative subjective pain scores using a visual analog scale from 0 to 10 and the number and type of oral dosing unit (tablets consumed) were taken from the medical record data. The average number of morphine milliequivalents taken among all of the patients during the postoperative period was 27.75. The mean total number of morphine sulfate immediate-release 15-mg tablets taken was 1.85. Average visual analog scale scores on days 3, 5, and 7 were 5.40, 4.50, and 2.25, respectively.

Conclusions: This study demonstrates that there may be rampant overprescription of opioids after foot and ankle surgery and that there is a protocol with significantly less opioid burden that is not inferior to current regimens.

一位外科医生使用低阿片类药物治疗足部和踝关节术后疼痛方案的经验。
背景:阿片类药物的流行在美国已经成为令人难以置信的问题,仅在2021年就导致8万多人死亡。在足部和踝关节手术文献中,没有研究试图制定一种多模式低阿片类药物术后疼痛方案。我们提出了一个回顾性评估20例患者谁开了一个新的术后低阿片类药物方案。方法:对接受足部和踝关节手术的患者进行简短的期望咨询,并告知他们每6小时服用400毫克布洛芬和1000毫克对乙酰氨基酚(一起或交替),并立即释放15毫克硫酸吗啡以缓解突破性疼痛。结果:术后主观疼痛评分采用视觉模拟评分0 ~ 10分,口服给药单位(片剂)的数量和类型从病历数据中获取。术后患者平均服用吗啡毫当量27.75毫克。硫酸吗啡速释15mg片平均总服用次数为1.85次。第3、5、7天的视觉模拟量表平均得分分别为5.40、4.50和2.25。结论:本研究表明,足部和踝关节手术后可能存在严重的阿片类药物过度处方,并且存在一种明显减少阿片类药物负担的方案,其效果并不逊色于目前的方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
128
审稿时长
6-12 weeks
期刊介绍: The Journal of the American Podiatric Medical Association, the official journal of the Association, is the oldest and most frequently cited peer-reviewed journal in the profession of foot and ankle medicine. Founded in 1907 and appearing 6 times per year, it publishes research studies, case reports, literature reviews, special communications, clinical correspondence, letters to the editor, book reviews, and various other types of submissions. The Journal is included in major indexing and abstracting services for biomedical literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信